157 related articles for article (PubMed ID: 18563296)
1. Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma.
Flaig TW; Kim FJ; La Rosa FG; Breaker K; Schoen J; Russ PD
Invest New Drugs; 2009 Feb; 27(1):83-7. PubMed ID: 18563296
[No Abstract] [Full Text] [Related]
2. [A case of pneumatosis cystoides intestinalis secondary to sunitinib treatment for renal cell carcinoma].
Ohtake S; Namura K; Fujikawa A; Sawada T; Ohta J; Moriyama M; Hayashi H
Hinyokika Kiyo; 2014 Feb; 60(2):75-8. PubMed ID: 24755817
[TBL] [Abstract][Full Text] [Related]
3. [A case of pneumatosis intestinalis associated with sunitinib treatment for renal cell carcinoma].
Choi YA; Sim EH; Lee KE; Ko SY; Seo MJ; Yang YJ; Park JC; Park SY
Korean J Gastroenterol; 2013 Jun; 61(6):347-50. PubMed ID: 23877217
[TBL] [Abstract][Full Text] [Related]
4. Pneumatosis cystoides intestinalis associated with sunitinib and a literature review.
Lee YS; Han JJ; Kim SY; Maeng CH
BMC Cancer; 2017 Nov; 17(1):732. PubMed ID: 29121860
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer.
Kalantari HR
Br J Cancer; 2009 Oct; 101(7):1222-3; author reply 1224. PubMed ID: 19755985
[No Abstract] [Full Text] [Related]
6. Skin depigmentation induced by sunitinib treatment of renal cell carcinoma.
Al Enazi MM; Kadry R; Mitwali H
J Am Acad Dermatol; 2009 Nov; 61(5):905-6. PubMed ID: 19836653
[No Abstract] [Full Text] [Related]
7. [Sunitinib-induced pyoderma gangrenosum].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2013 Dec; 140(12):841-2. PubMed ID: 24315238
[No Abstract] [Full Text] [Related]
8. Two cases of bowel perforation associated with sunitinib treatment for renal cell carcinoma.
Hoshino Y; Hasegawa H; Ishii Y; Endo T; Ochiai H; Okabayashi K; Kaneko G; Mikami S; Mukai M; Oya M; Kitagawa Y
Int J Clin Oncol; 2012 Aug; 17(4):412-6. PubMed ID: 21927829
[TBL] [Abstract][Full Text] [Related]
9. Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma.
Yıldız I; Varol U; Şen F; Kılıç L
Anadolu Kardiyol Derg; 2014 Nov; 14(7):654-6. PubMed ID: 25163084
[No Abstract] [Full Text] [Related]
10. Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis.
O'Donnell PH
BJU Int; 2011 Oct; 108(8):1284-5. PubMed ID: 21418138
[No Abstract] [Full Text] [Related]
11. Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy.
van der Veldt AA; van den Eertwegh AJ; Hoekman K; Barkhof F; Boven E
Ann Oncol; 2007 Oct; 18(10):1747-50. PubMed ID: 17890217
[No Abstract] [Full Text] [Related]
12. Pneumatosis intestinalis and bowel perforation associated with molecular targeted therapy: an emerging problem and the role of radiologists in its management.
Shinagare AB; Howard SA; Krajewski KM; Zukotynski KA; Jagannathan JP; Ramaiya NH
AJR Am J Roentgenol; 2012 Dec; 199(6):1259-65. PubMed ID: 23169717
[TBL] [Abstract][Full Text] [Related]
13. Re: Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.
van den Meiracker AH; Danser AH; Sleijfer S; Kappers MH
J Natl Cancer Inst; 2011 Oct; 103(20):1557; author reply 1558. PubMed ID: 21862728
[No Abstract] [Full Text] [Related]
14. Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Feldman DR; Martorella AJ; Robbins RJ; Motzer RJ
J Natl Cancer Inst; 2007 Jun; 99(12):974-5; author reply 976-7. PubMed ID: 17565156
[No Abstract] [Full Text] [Related]
15. Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Garfield DH; Hercbergs A; Davis PJ
J Natl Cancer Inst; 2007 Jun; 99(12):975-6; author reply 976-7. PubMed ID: 17565154
[No Abstract] [Full Text] [Related]
16. Response to 'Thyrotoxicosis during sunitinib treatment for renal cell carcinoma' by Grossmann et al.
Daniels GH
Clin Endocrinol (Oxf); 2009 Sep; 71(3):455. PubMed ID: 19138312
[No Abstract] [Full Text] [Related]
17. Acute cardiac failure after sunitinib.
Machiels JP; Bletard N; Pirenne P; Jacquet L; Bonbled F; Duck L
Ann Oncol; 2008 Mar; 19(3):597-9. PubMed ID: 18272908
[No Abstract] [Full Text] [Related]
18. Sunitinib-induced thyrotoxicosis.
Piñar D; Boix E; Meana JA; Herrero J
J Endocrinol Invest; 2009 Dec; 32(11):941-2. PubMed ID: 19636224
[No Abstract] [Full Text] [Related]
19. Reply: To PMID 23169717.
Shinagare AB; Ramaiya NH
AJR Am J Roentgenol; 2013 Aug; 201(2):W370. PubMed ID: 23883264
[No Abstract] [Full Text] [Related]
20. Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinib.
Coriat R; Ropert S; Mir O; Billemont B; Chaussade S; Massault PP; Blanchet B; Vignaux O; Goldwasser F
Invest New Drugs; 2011 Oct; 29(5):1090-3. PubMed ID: 20524036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
